392 related articles for article (PubMed ID: 30143460)
1. COPD assessment test as a possible tool for evaluating health-related quality of life in lymphangioleiomyomatosis.
Kato M; Kanehiro Y; Yoshimi K; Kodama Y; Sekiya M; Sato T; Takahashi K; Seyama K;
Respir Investig; 2018 Nov; 56(6):480-488. PubMed ID: 30143460
[TBL] [Abstract][Full Text] [Related]
2. Long-term efficacy and safety of sirolimus therapy in patients with lymphangioleiomyomatosis.
Hu S; Wu X; Xu W; Tian X; Yang Y; Wang ST; Liu S; Xu X; Xu KF
Orphanet J Rare Dis; 2019 Aug; 14(1):206. PubMed ID: 31429781
[TBL] [Abstract][Full Text] [Related]
3. Is sirolimus a therapeutic option for patients with progressive pulmonary lymphangioleiomyomatosis?
Neurohr C; Hoffmann AL; Huppmann P; Herrera VA; Ihle F; Leuschner S; von Wulffen W; Meis T; Baezner C; Leuchte H; Baumgartner R; Zimmermann G; Behr J
Respir Res; 2011 May; 12(1):66. PubMed ID: 21600034
[TBL] [Abstract][Full Text] [Related]
4. The St. George's Respiratory Questionnaire in lymphangioleiomyomatosis.
Xu KF; Wang L; Tian XL; Gui YS; Peng M; Cai BQ; Zhu YJ
Chin Med Sci J; 2010 Sep; 25(3):140-5. PubMed ID: 21180274
[TBL] [Abstract][Full Text] [Related]
5. St. George's Respiratory Questionnaire has longitudinal construct validity in lymphangioleiomyomatosis.
Swigris JJ; Lee HS; Cohen M; Inoue Y; Moss J; Singer LG; Young LR; McCormack FX;
Chest; 2013 Jun; 143(6):1671-1678. PubMed ID: 23328755
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the MILES cohort reveals determinants of disease progression and treatment response in lymphangioleiomyomatosis.
Gupta N; Lee HS; Young LR; Strange C; Moss J; Singer LG; Nakata K; Barker AF; Chapman JT; Brantly ML; Stocks JM; Brown KK; Lynch JP; Goldberg HJ; Downey GP; Taveira-DaSilva AM; Krischer JP; Setchell K; Trapnell BC; Inoue Y; McCormack FX;
Eur Respir J; 2019 Apr; 53(4):. PubMed ID: 30846465
[TBL] [Abstract][Full Text] [Related]
7. Sustained effects of sirolimus on lung function and cystic lung lesions in lymphangioleiomyomatosis.
Yao J; Taveira-DaSilva AM; Jones AM; Julien-Williams P; Stylianou M; Moss J
Am J Respir Crit Care Med; 2014 Dec; 190(11):1273-82. PubMed ID: 25329516
[TBL] [Abstract][Full Text] [Related]
8. The COPD assessment test and St George's Respiratory Questionnaire: are they equivalent in subjects with COPD?
Morishita-Katsu M; Nishimura K; Taniguchi H; Kimura T; Kondoh Y; Kataoka K; Ogawa T; Watanabe F; Arizono S; Nishiyama O; Nakayasu K; Imaizumi K; Hasegawa Y
Int J Chron Obstruct Pulmon Dis; 2016; 11():1543-51. PubMed ID: 27462150
[TBL] [Abstract][Full Text] [Related]
9. A Novel Quantitative Computed Tomographic Analysis Suggests How Sirolimus Stabilizes Progressive Air Trapping in Lymphangioleiomyomatosis.
Argula RG; Kokosi M; Lo P; Kim HJ; Ravenel JG; Meyer C; Goldin J; Lee HS; Strange C; McCormack FX;
Ann Am Thorac Soc; 2016 Mar; 13(3):342-9. PubMed ID: 26799509
[TBL] [Abstract][Full Text] [Related]
10. Functional improvements in patients with lymphangioleiomyomatosis after sirolimus: an observational study.
Zhan Y; Shen L; Xu W; Wu X; Zhang W; Wang J; Li X; Yang Y; Tian X; Xu KF
Orphanet J Rare Dis; 2018 Feb; 13(1):34. PubMed ID: 29458386
[TBL] [Abstract][Full Text] [Related]
11. Serum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial.
Young L; Lee HS; Inoue Y; Moss J; Singer LG; Strange C; Nakata K; Barker AF; Chapman JT; Brantly ML; Stocks JM; Brown KK; Lynch JP; Goldberg HJ; Downey GP; Swigris JJ; Taveira-DaSilva AM; Krischer JP; Trapnell BC; McCormack FX;
Lancet Respir Med; 2013 Aug; 1(6):445-52. PubMed ID: 24159565
[TBL] [Abstract][Full Text] [Related]
12. Functional performance in patients with COPD: association with treatment regimen, GOLD group, lung function, and symptom burden in a cross-sectional study.
Ding B; Judge D; Small M; Bent-Ennakhil N; Siddiqui S
Int J Chron Obstruct Pulmon Dis; 2018; 13():2785-2796. PubMed ID: 30233169
[TBL] [Abstract][Full Text] [Related]
13. Reduced physical activity in lymphangioleiomyomatosis compared with COPD and healthy controls: disease-specific impact and clinical correlates.
Bahmer T; Watz H; Waschki B; Gramm M; Magnussen H; Rabe KF; Wirtz H; Kirsten D; Kirsten A
Thorax; 2016 Jul; 71(7):662-3. PubMed ID: 26968971
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of a linear analog scale questionnaire to measure health-related quality of life in elderly patients with chronic obstructive pulmonary disease.
Katsura H; Yamada K; Kida K
J Am Geriatr Soc; 2003 Aug; 51(8):1131-5. PubMed ID: 12890078
[TBL] [Abstract][Full Text] [Related]
15. [Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].
Ning P; Guo YF; Sun TY; Zhang HS; Chai D; Li XM
Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):679-83. PubMed ID: 27586974
[TBL] [Abstract][Full Text] [Related]
16. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis.
Bissler JJ; McCormack FX; Young LR; Elwing JM; Chuck G; Leonard JM; Schmithorst VJ; Laor T; Brody AS; Bean J; Salisbury S; Franz DN
N Engl J Med; 2008 Jan; 358(2):140-51. PubMed ID: 18184959
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of different evaluation systems for assessing disease severity and treatment efficacy in patients with chronic obstructive pulmonary disease].
Tan M; Jian W; Liang Q; Li S; Cui H
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):1119-1124. PubMed ID: 34308866
[TBL] [Abstract][Full Text] [Related]
18. Nitrogen single-breath washout test for evaluating exercise tolerance and quality of life in patients with chronic obstructive pulmonary disease.
Deus CAL; Vigário PS; Guimarães FS; Lopes AJ
Braz J Med Biol Res; 2018; 51(4):e7059. PubMed ID: 29490001
[TBL] [Abstract][Full Text] [Related]
19. Factors Associated With Quality of Life in Subjects With Stable COPD.
Ekici A; Bulcun E; Karakoc T; Senturk E; Ekici M
Respir Care; 2015 Nov; 60(11):1585-91. PubMed ID: 26152471
[TBL] [Abstract][Full Text] [Related]
20. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].
Long H; Luo H; Chen P; Li Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
